Summary of key recommendations: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Hypercholesterolemia}} {{CMG}} ==Summary of Key Recommendations for the Treatment of Blood Cholesterol to Reduce ASCVD Risk in Adults== {|class="wikitable" style=..." |
No edit summary |
||
| Line 53: | Line 53: | ||
|- | |- | ||
|} | |} | ||
==References== | |||
{{Reflist|2}} | |||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
[[CME Category::Cardiology]] | |||
[[Category:Disease]] | |||
[[Category:Cardiology]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Up-To-Date cardiology]] | |||
Revision as of 17:31, 27 October 2016
Template:Hypercholesterolemia Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Summary of Key Recommendations for the Treatment of Blood Cholesterol to Reduce ASCVD Risk in Adults
| Class I |
| "1. RECOMMENDATION 1 HERE(Level of Evidence: A)" |
| "2. RECOMMENDATION 2 HERE(Level of Evidence: B)" |
| Class III (Harm) |
| "1. RECOMMENDATION 1 HERE (Level of Evidence: C)" |
| "2. RECOMMENDATION 2 HERE (Level of Evidence: C)" |
| Class III (No Benefit) |
| "1. RECOMMENDATION 1 HERE (Level of Evidence: C)" |
| "2. RECOMMENDATION 2 HERE (Level of Evidence: C)" |
| Class IIa |
| "1. RECOMMENDATION 1 HERE (Level of Evidence: C)" |
| "2. RECOMMENDATION 2 HERE (Level of Evidence: C)" |
| Class IIb |
| "1. RECOMMENDATION 1 HERE (Level of Evidence: C)" |
| "2. RECOMMENDATION 2 HERE (Level of Evidence: C)" |